0 Comments
0 Shares
1636 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
- Please log in to like, share and comment!
- Castrate-Resistant Prostate Cancer Market Opportunities and Forecast Analysis 2032Castrate-resistant prostate cancer (CRPC) is a severe form of prostate cancer that advances despite treatments aimed at reducing androgen levels. CRPC presents significant challenges in treatment as standard hormone therapies lose their effectiveness. With increasing awareness and rising cases globally, the CRPC market is expanding. This article outlines the epidemiology of CRPC, offers...0 Comments 0 Shares 239 Views 0 Reviews
- Castration-Resistant Prostate Cancer HRPCA Therapeutics Market Size, Analysis and Forecast 2031The Castration-Resistant Prostate Cancer HRPCA Therapeutics Market in 2023 is US$ 12.41 billion, and is expected to reach US$ 25.32 billion by 2031 at a CAGR of 9.3%. FutureWise Research published a report that analyzes Castration-Resistant Prostate Cancer HRPCA Therapeutics Market trends to predict the market's growth. The report begins with a description of the business environment and...0 Comments 0 Shares 516 Views 0 Reviews
- Hormone Refractory Prostate Cancer Market 2022 – Industry Sectors, Drivers, Forecast to 2029Analysts expect the global Hormone Refractory Prostate Cancer market to grow at a 9.68% CAGR over the period 2022-2029. Overview of the Market The Hormone Refractory Prostate Cancer Market 2022-2029 Report offers a comprehensive assessment of the market. It provides detailed analysis through qualitative insights, historical data and sustainable market size projections. The forecasts...0 Comments 0 Shares 2765 Views 0 Reviews
- Hormone Sensitive Prostate Cancer Market Size, Overview, Share and Forecast 2031The Hormone Sensitive Prostate Cancer Market in 2023 is US$ 12.44 billion, and is expected to reach US$ 22.05 billion by 2031 at a CAGR of 7.42%. FutureWise Research published a report that analyzes Hormone Sensitive Prostate Cancer Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain...0 Comments 0 Shares 628 Views 0 Reviews
- Prostate Cancer Antigen 3 (PCA3) Test Market is set to Witness Huge Demand at a CAGR of 12.4% in the forecast period 2029The prostate cancer antigen 3 (PCA3) test looks for genetic material (messenger RNA (mRNA)) produced exclusively by the prostate. In normal prostate tissue, the protein PCA3 and its associated mRNA are present at low levels. PCA3 is found in high concentrations (overexpressed) in approximately 90% of prostate cancers. Prostate specific antigen (PSA) is also increased in prostate...0 Comments 0 Shares 1579 Views 0 Reviews
- Cancer Immunotherapy Market is Slated to Witness Tremendous Growth in Coming Years: 2023-2028The Cancer Immunotherapy Market research study offers stakeholders in-depth insights into the dynamics of the market and its different fragmentations. This study provides stakeholders with comprehensive industry elements through detailed-driven information that is based on reliable, impartial, and accurate data. The study offers in-depth qualitative and quantitative insights on market...0 Comments 0 Shares 10377 Views 0 Reviews
- Castrate Resistant Prostate Cancer Market is Estimated To Witness High Growth Owing To Increased Castrate Resistant Prostate Cancer IncidencesThe Castrate Resistant Prostate Cancer Market is estimated to be valued at US$ 11.12 Bn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. The castrate resistant prostate cancer market comprises drugs used for treatment of prostate cancer that has spread to other parts of the body even...0 Comments 0 Shares 1410 Views 0 Reviews
- Current Demand and Developing Trends in the Prostate Cancer Treatment Market – MarkNtel AdvisorsProstate Cancer Treatment Market research report by Markntel Advisors is an accurate, unbiased, and reliable comprehension and study of data obtained from trustworthy and factual sources to equip the stakeholder with a well-researched and detail-driven report regarding the fluctuations in the industry. The report aims to provide detailed information about the nooks and crannies of the...0 Comments 0 Shares 1859 Views 0 Reviews
- Emerging Imaging Technologies for Prostate Cancer MarketThe Castrate Resistant Prostate Cancer (CRPC) Market is a type of prostate cancer that continues to grow and spread even after the patient has undergone hormone therapy to lower testosterone levels. The market for CRPC treatments is focused on developing therapies that can effectively manage the disease and improve patient outcomes. The CRPC market includes a range of treatment options,...0 Comments 0 Shares 1613 Views 0 Reviews
- Global Market for Non-metastatic Prostate Cancer (nmPC): Epidemiology and Treatment Outlook to 2034Introduction Non-metastatic prostate cancer (nmPC) refers to localized prostate cancer that has not spread beyond the prostate gland or adjacent tissues. Despite its non-metastatic status, nmPC poses a significant healthcare challenge due to its potential to progress to advanced stages if left untreated. With advancements in diagnostics and treatment options, the Non-metastatic Prostate...0 Comments 0 Shares 123 Views 0 Reviews
More Results